US EditionPublished • loading... • Updated
Illumina and Grail Veterans Launch Hepta With First Liquid Biopsy-Native AI That Detects Liver Disease With Tissue-Level Biological Insights
Summary by Hastings Tribune
2 Articles
2 Articles
Exclusive: Ex-Illumina and Grail employees raise $6.7M to spot liver disease
Former Illumina, Grail and Google employees are adapting the same blood-based DNA technology used in cancer and prenatal screening to diagnose chronic conditions like liver disease. Their new company, Hepta Bio, raised $6.7 million in ...
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
